Correlation Between Plus Therapeutics and Revelation Biosciences
Can any of the company-specific risk be diversified away by investing in both Plus Therapeutics and Revelation Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Plus Therapeutics and Revelation Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Plus Therapeutics and Revelation Biosciences, you can compare the effects of market volatilities on Plus Therapeutics and Revelation Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Plus Therapeutics with a short position of Revelation Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Plus Therapeutics and Revelation Biosciences.
Diversification Opportunities for Plus Therapeutics and Revelation Biosciences
0.12 | Correlation Coefficient |
Average diversification
The 3 months correlation between Plus and Revelation is 0.12. Overlapping area represents the amount of risk that can be diversified away by holding Plus Therapeutics and Revelation Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Revelation Biosciences and Plus Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Plus Therapeutics are associated (or correlated) with Revelation Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Revelation Biosciences has no effect on the direction of Plus Therapeutics i.e., Plus Therapeutics and Revelation Biosciences go up and down completely randomly.
Pair Corralation between Plus Therapeutics and Revelation Biosciences
Given the investment horizon of 90 days Plus Therapeutics is expected to generate 0.44 times more return on investment than Revelation Biosciences. However, Plus Therapeutics is 2.26 times less risky than Revelation Biosciences. It trades about 0.0 of its potential returns per unit of risk. Revelation Biosciences is currently generating about -0.07 per unit of risk. If you would invest 184.00 in Plus Therapeutics on September 12, 2024 and sell it today you would lose (53.00) from holding Plus Therapeutics or give up 28.8% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Plus Therapeutics vs. Revelation Biosciences
Performance |
| Timeline |
| Plus Therapeutics |
| Revelation Biosciences |
Plus Therapeutics and Revelation Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Plus Therapeutics and Revelation Biosciences
The main advantage of trading using opposite Plus Therapeutics and Revelation Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Plus Therapeutics position performs unexpectedly, Revelation Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Revelation Biosciences will offset losses from the drop in Revelation Biosciences' long position.| Plus Therapeutics vs. Revelation Biosciences | Plus Therapeutics vs. Virax Biolabs Group | Plus Therapeutics vs. Neurobo Pharmaceuticals | Plus Therapeutics vs. Allarity Therapeutics |
| Revelation Biosciences vs. Virax Biolabs Group | Revelation Biosciences vs. Kiora Pharmaceuticals | Revelation Biosciences vs. ZyVersa Therapeutics | Revelation Biosciences vs. Sonnet Biotherapeutics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Complementary Tools
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |